Contents include:

• Continuing to deliver during a pandemic: The acceleration of “virtual” practice
• How pharmacists can transform their practice around the air pollution
• Interview with André Bédat 2020 awardee and pharmaceutical care innovator Martin Schulz
• How COVID-19 has changed the future of drug development
• How to be an agent of change for women in science and education
• Advancing cancer therapies through mathematics and trial design
• Harnessing the therapeutic potential of gut microbes
• And more reports from FIP Virtual 2020 and the 7th Pharmaceutical Sciences World Congress

Contents include: 

• Interview with Gary Kobinger, whose team developed the Ebola vaccine
  
• How COVID-19 is affecting pharmacists on front lines around the world
  
• Engaging children in medicines safety
  
• Preventing arbovirus diseases: A growing public health focus
  
• The discharge medicines review service in Wales
  
• Nine things about the WHO Immunization agenda 2030
  
• Towards patient safety through better recognition of pharmacists in Ecuador
  

• Preview of imminent OECD findings on primary health care
• Interview with Meindert Danhof, the founding father of pharmacological models
• Pharmacists combating tick-borne encephalitis
• Addressing the challenge of remuneration and sustainability of services
• Door opens to broader primary care role for community pharmacists in France
• Harnessing the science of prediction for better patient care
• How to disrupt, innovate and create value for your faculty
• Links being drawn between AMR and environmental pollution
• Research to protect patients from impurities in medicines
• Making a difference in Yemen

• How mHealth applications are improving the quality of primary health care services
• How emerging vaccine technologies are pushing disease prevention boundaries
• Evidence supports development of a pharmacy service to screen children for hypercholesterolaemia
• Pharmacists beating non-communicable diseases in the community
• Interview with Sandra Carey, global president at McCann Health Global Pharmacy
• Strengthening the role of pharmacists in primary health care in Turkey
• How Indonesia’s pharmacists are developing their primary healthcare workforce
• How US medical practices are integrating more pharmacists into primary healthcare teams
• Thoughts from Fred Mayer, the USA’s “father of public health pharmacy”
• Why we must encourage people to become active managers of their own health
• Reports from the FIP Regional Conference for the Middle Eastern Region

Content includes:

• Pharmacy “Amazonified”: What it could mean. 
• FIP’s new president on modernisation. 
• How nanotechnology breakthroughs are transforming cancer care.
• Is antibiotic stewardship always effective?
• Simplification: The WHO approach to eliminating hepatis C.
• Pharmacogenetics services from community pharmacies.
• How avatars can help improve counselling skills.
• Conflict management: Take the offensive.
• How to develop a strategic perspective for your faculty.

Contents include: 

• How pharmacists can improve adherence in the elderly. 
• Tackling dementia: New drugs, new approaches, new hope. 
• Long-term care: Optimising outcomes and being versatile. 
• How pharmacies are helping to create age-friendly communities. 
• Equipping health systems for 2030 and beyond. 
• Ensuring health and happiness for Finland’s ageing

Contents include:

• Lebanon: Pharmacists have huge potential in the refugee crisis but must act now
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• Neurological disease and cancer drugs are “hot” but scientists must consider market forces
• Are you ready for Generation C?
• Medicines shortages: What progress has been made?
• Good enough is dead! Technology must be integrated into pharmacy education

Contents include:

• “End-to-end thinking” is paving the way to future medicines
• Non-profit pharma companies offering a new route to medicines
• Interview Hiroaki Kitano: Systems biology is changing health care
• Pharmaceutical Sciences World Congress reports
• Developing a postgraduate course in global pharmacy
• U-turn in Israel recognises pharmacists’ value

Contents include:

• Achieving responsible use of antimicrobial medicines
• Rising to the challenge of reducing the global burden of disease
• Stemming the tide of dementia in science
• Nalfurafine: The first non-addictive opioid agonist
• Regulatory approaches accelerate access to medicines
• Health care education and labour markets must change

Contents include:

• Interview Jim Campbell: No health without a workforce — a plan for the world
• Continuous manufacturing: What does it mean for the pharmaceutical workforce?
• Are pharmacists happy with their work?
• Free movement of pharmacists in Europe: Regulation and impact
• Brain drain/Brain gain: We need better intelligence
• Building professional capacity in Ethiopia

Contents include:

• Leading pharmacies in complex and uncertain times 
• Epigenetics is providing exciting targets for future medicines
• Look beyond your immediate community: practise in low-resource and emergency settings
• Global issues forge the path for global pharmacy citizens to follow
• Social responsibility should be part of business as usual
• Pharmacy and advocacy the Swiss way

Contents include:

• Interview Lee Vermeulen: Inspiring developments in hospital pharmacy through international standards
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• New omega-3-related compound kills breast cancer cells with little sign of side effects
• Pharmacists have proved essential in the Ebola crises
• New technologies to track compliance and administration
• Increasing responsibilities of technicians need to be acknowledged

Contents include:

• Getting practical: the FIP project giving students much needed lab experience
• Crowd power being applied to research
• New pharmacy services and better care for patients with multiple sclerosis
• How real-world data are improving access to medicines
• What might be the quickest path to equip hospital pharmacists for the information age?
• ​Big data and the pharmacist — caution advised

Contents include:

• Interview Otmar Kloiber: Together we can prove our value better 
• Partnerships developing treatments: tips for success
• Developing markets where pharmacists are seen as part of the team
• Patient partnerships giving future pharmacists better skills
• Advanced pharmacy practice — the US landscape Healthcare for nomads and other challenges

Contents include:

• Interview with Carmen Peña Professional obligation: An oath for pharmacists
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• HIV/AIDS, tuberculosis and Fabry disease: how shortages affect patients
• Scientists join public-private partnership to advance regulatory process
• Pharmacy bodies could take a greater role in assuring GPP
• Bright future for pharmacists in industry but no job entitlement

Contents include:

• How virtual R&D is leading to treatments for neglected diseases
• Getting drugs to the brain using modified nanocarriers
• Could we be dispensing alendronate patches in future?
• Quality by design means linking the lab to the patient early on
• How genomics can enhance drug therapy
• What Asia needs to do to foster pharmaceutical sciences

Contents include:

• Pharmacy practice in daily life Complexity everywhere?
• World Congress of Pharmacy and Pharmaceutical Sciences reports
• The Basel Statements: Where are we now?
• Managing mentally ill patients: The Role of the Pharmacist
• Better quality pharmacy education produces better pharmacists
• Pharmaceutical sciences: Approaching the Future in Drug Delivery

Contents include:

• How I hope to give back to the world by being a pharmacist
• The journey thus far: pharmacy practice across continent
• Developing medicines that are suitable for use by children
• Providing preventative care services in a community pharmacy
• Battling the tuberculosis pandemic in India
• Never stop investing in yourself, never stop learning

Contents include:

• Ensuring more responsible use of medicines: A report from the FIP stakeholders roundtables
• Improving the responsible use of OTC products
• Economics of pharmacy
• Increased legal, social, and professional accountability
• Traditional process vs. innovative practice
• Past and future impact of drug development on healthcare

Contents include:

• Global pharmacy education: Are we nearly there yet?
• New challenges in Russia: Education responds to industry
• Compounding in Brazil: Legal compliance for future progress
• Change in community pharmacy policy: How are we creating it in Taiwan?
• Team based care: Starting with the pharmacy team
• Generating care: improving adherence through pharmacy practice

Contents include:

• Global reporting initiative: Reporting sustainability sector by sector
• Decreased cost via increased access: A technology solution for sustainability
• Rebuilding pharmaceutical systems in Afghanistan
• Pharmaceutical systems development in sub-Saharan Africa: a call to action
• The FIP Young Pharmacists Group supporting sustainability
• The Amsterdam declaration: Creating a sustainable future at the FIP centennial congress

Contents include:

• World Congress of Pharmacy and Pharmaceutical Sciences reports
• A reason to change Flushing our future Counterfeits
• The magic of networking Recollections of a first timer

Contents include:

• Paediatric HIV/AIDS drug formulation development: A cost reducing strategy
• Fighting disease with attitude: Changing attitudes and behaviours about medicines in
• Paraguay Crisis management: Legal ramifications for pharmacy practice in the face of disaster
• A rising killer: Non-communicable diseases in development countries
• Looking outward and forward: Fighting neglected disease with pharmaceutical sciences
• Neglected diseases: A public health problem of low and middle-income countries only?
• A perspective from Mexico

Contents include:

• Hands off medicines enabling good dispensing practices
• Empowering patient minority populations self-medication management program for adult patients in custody
• ​The value of pharmaceutical innovation global versus Indian prospective
• Culture cross, minds meet: Uniting global scientists, highlighting pharmaceutical innovations at the
• Pharmaceutical Sciences World Congress 2010
• Broadening the vision: Expanding pharmacy education across borders
• Innovation in education: Using the national science festival in
• South Africa to raise awareness of the prevention of chronic diseases

Contents include:

• Leading FIP into the future: Dr Michel Buchmann
• Counterfeiting high on agendas Increased responsibility: The changing role of pharmacists
• The FIP Academic Institutional Membership: Aiming high at the inaugural deans’ forum
• Telepharmacy: bridging the pharmacy services gap in rural and underserviced areas
• Learning to teach: Workshop report

Contents include:

• Making a difference: Pharmacists on the headline
• Infectious disease: pharmacists involvement in medically-related global activities
• Education and patient outcomes: A call for a needs-based approach
• Continuing professional development in pharmacy practice: Is it really about learning to learn or legislating learning?
• ​Practice, progression and regulation: Widening the discussion

Contents include:

• The rise of interdisciplinary approaches: How scientists are working together for international development 
• Collaborative care of pediatric oncology patients: Focus on the pharmacy team
• Collaborative development of a health system-focused cardiology elective: Bringing a practice site into the classroom
• How to get together: A collaborative help network
• The light at the end of the tunnel? A hopeful beginning for a malaria vaccine
• Genomics in the development of vaccines

Content includes: 

• Reengineering Pharmacy Practice in a Changing World
• Cancers in Developing Countries
• Look how far we’ve come, or have we?
• Competence in the Global Pharmacy Workforce
• Responsibility for Patient Outcomes: Are You Ready?

Content includes: 

• Industrial Manufacturing in 2020
• Chronopharmaceutics
• Global Conference on the Future of Hospital Pharmacy
• Historical non-involvement and future opportunities
• Interprofessional collaboration as a catalyst for change

Content includes: 

• Evidence: Measurable, Tangible and Powerful
• Stopping the Most Avoidable Risk
• A Comprehensive Future
• The Future of Pharmacy
• It Will Never Happen To Me. But It Could

Content includes: 

FIP and WHO Establish the Pharmacy Education Taskforce
Pharmacy Education in Finland
Pharmacy Students are moving on – but how was the Journey?
23 Hard Questions for Pharmacy Educators
Dr Kamal K Midha Addresses the Pharmaceutical Sciences World Congress 2007